Tumor News and Research

RSS

Phenotypic plasticity may allow cancer cells to evade standard therapy

Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.

20 Dec 2022

Novel approach could pave the way for new treatments to prevent relapse in breast cancer patients

Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice.

20 Dec 2022

User-friendly complete system for more targeted, effective thermal ablation of tumors

Image-guided thermal ablation therapy is a patient-friendly, minimally invasive, and cost-effective tumor treatment method.

19 Dec 2022

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway.

19 Dec 2022

Study shows positive effect of concentrating surgery for children with neuroblastoma

Neuroblastoma is a tumor of the sympathetic nervous system that occurs mainly in young children. Every year, 25 children in the Netherlands receive this diagnosis. Surgery to remove the tumor tissue forms an important part of the treatment plan.

19 Dec 2022

New imaging agent lights the way for surgeons during lung cancer surgery

Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as well as on the skill of the surgeon.

19 Dec 2022

FDA approves targeted imaging agent for use in lung cancer surgery

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery.

18 Dec 2022

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.

16 Dec 2022

Researchers identify a small number of 'cheating' cancer cells under hypoxia

Researchers at UConn Health, Yale, and Johns Hopkins have identified that some cancer cells can "cheat" through escaping constraints imposed by lack of oxygen, allowing the cancer cells to continue to grow.

16 Dec 2022

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

The Children’s Tumor Foundation (CTF) has announced a groundbreaking 3-year study, which it will fund for nearly $2 million, to determine if a DNA-based blood test can offer better understanding and ultimately earlier diagnosis of cancer predisposition in neurofibromatosis type 1 (NF1) patients.

16 Dec 2022

Novel immunotherapy offers a promising new strategy to fight hard-to-treat cancers

Scientists at UC San Francisco have engineered T cells to produce a potent anti-cancer cytokine, but only when they encounter tumor cells.

16 Dec 2022

Study reveals subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma

Researchers from the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered a novel subtype of Epstein-Barr Virus (EBV)-positive nasopharyngeal carcinoma (NPC) and EBV-associated immunosuppression in the tumor microenvironment (TME).

16 Dec 2022

Experimental therapy shows promise as treatment for metastatic colon cancer in preclinical models

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators.

16 Dec 2022

Using synthetic gene circuits to better control the timing of immunotherapy

In two separate studies, researchers demonstrate how synthetic biology can be used to tackle a difficult issue in cancer immunotherapy: the way immunotherapy-related approaches focused on short-term killing of tumor cells may fail to eradicate tumors because growth of tumors happens on longer timescales.

16 Dec 2022

Researchers identify a new target gene in pancreatic ductal adenocarcinoma

Pancreatic cancer remains one of the deadliest malignancies worldwide. Since five-year survival rate for pancreatic ductal adenocarcinoma (PDAC) is only about 3% in patients, PDAC is very difficult to treat with surgery worldwide.

16 Dec 2022

Imaging method yields highly accurate and precise values of radionuclide organ uptake

Patients with cancer that has spread to the bone are sometimes treated with alpha particle radiation therapy that is delivered into or very close to the tumor.

16 Dec 2022

Activated vitamin D3 inhibits arsenic-mediated carcinogenesis in certain skin cells, research shows

According to recent estimates, over 140 million people from 50 countries regularly get exposed to arsenic through drinking water.

16 Dec 2022

Eating flowers to promote health and prevent disease

Do people eat flowers? Yes, many of them. Experts say that the Greeks, Romans, and French during the Middle Ages and the English during the Victorian era included edible flowers in their cuisine, either as appetizers or to enhance the flavor of the dish.

15 Dec 2022

Researchers discover how certain breast cancers persist after chemo and do not respond to immunotherapies

Thanks to advances in cancer therapies, most forms of breast cancer are highly treatable, especially when caught early.

15 Dec 2022

Research: Patient's race may influence recommendations for surgical resection of brain tumors

Published in The Lancet, University of Minnesota Medical School researchers found a patient's race may influence recommendations for surgical removal of brain tumors.

15 Dec 2022

Tumor News and Research

Phenotypic plasticity may allow cancer cells to evade standard therapy

Novel approach could pave the way for new treatments to prevent relapse in breast cancer patients

User-friendly complete system for more targeted, effective thermal ablation of tumors

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Study shows positive effect of concentrating surgery for children with neuroblastoma

New imaging agent lights the way for surgeons during lung cancer surgery

FDA approves targeted imaging agent for use in lung cancer surgery

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

Researchers identify a small number of 'cheating' cancer cells under hypoxia

Study to determine if a DNA-based blood test can help detect cancer predisposition in NF1 patients

Novel immunotherapy offers a promising new strategy to fight hard-to-treat cancers

Study reveals subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma

Experimental therapy shows promise as treatment for metastatic colon cancer in preclinical models

Using synthetic gene circuits to better control the timing of immunotherapy

Researchers identify a new target gene in pancreatic ductal adenocarcinoma

Imaging method yields highly accurate and precise values of radionuclide organ uptake

Activated vitamin D3 inhibits arsenic-mediated carcinogenesis in certain skin cells, research shows

Eating flowers to promote health and prevent disease

Researchers discover how certain breast cancers persist after chemo and do not respond to immunotherapies

Research: Patient's race may influence recommendations for surgical resection of brain tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News